Tumor markers in breast cancer

Medicina

Volumn 62, Issue 1, 2002, Pages 73-82

  Coronato, Silvia ^a   Laguens, Graciela E ^a   Spinelli, Osvaldo M ^a   Di Girolamo, Wanda ^a  

^a FACULTAD DE CIENCIAS MÉDICAS   (Argentina)

Author keywords

Breast cancer; Neoplasias; Tumor markers

Indexed keywords

TUMOR MARKER;

ARTICLE; BREAST CANCER; CANCER DIAGNOSIS; CANCER MORTALITY; CANCER RISK; CANCER THERAPY; CONTROLLED STUDY; DIAGNOSTIC PROCEDURE; FEMALE; HUMAN; MOLECULAR BIOLOGY; PREDICTION; PROGNOSIS; BLOOD; BREAST TUMOR; CLASSIFICATION; GENETIC MARKER; GENETICS; REVIEW;

BREAST NEOPLASMS; FEMALE; GENETIC MARKERS; HUMANS; TUMOR MARKERS, BIOLOGICAL;

EID: 0036213199     PISSN: 00257680     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (70)

1. Critical evaluation of prognostic factors
2. Marcadores moleculares para predecir el pronóstico del cáncer de mama
3. Prognostic-predictive factors and therapeutic choices in invasive carcinoma of the breast
4. Predictive value of p53, mdm-2, p21, and mib-1 for chemotherapy response in advanced breast cancer
5. Tumour marker measurements in the diagnosis and monitoring of breast cancer
6. Circulating tumor markers in breast cancer: Accepted utilities an novel prospects
7. The biological role of mucins in cellular interactions and immune regulation: Prospects for cancer immunotherapy
8. Circulating anti-CEA antibodies in the sera of patients with breast cancer
9. Selection of appropriate cellular and molecular biologic diagnostic tests in the evaluation of cancer
10. Prognostic and predictive factors in breast cancer by immunohistochemical analysis
11. Prognostic factors in breast cancer
12. Micrometastases to axillary lymph nodes from carcinoma of the breast. Detection by immunohistochemistry and prognostic significance
13. Individual characterisation of the metastatic capacity of human breast carcinoma
14. The role of sentinel lymph node biopsy in women undergoing prophylactic mastectomy
15. Functional lymphatic anatomy for sentinel node biopsy in breast cancer: Echoes from the past and the periareolar blue method
16. Histologic grading and prognosis in breast cancer: A study of 1709 cases of which 359 have been followed for 15 years
17. Nucleoalar grading of breast cancer
18. The Nottingham prognosis index (NPI) a combination of multiple prognostic factors derived from the Nottingham Tenovus primary cancer study
19. Lobular carcinoma of the breast: An overview
20. Estrogen receptor status of breast cancer: A marker of different stages of tumor or different entities of the disease?
21. Activation of the Estrogen-Signaling Pathway by p21 (WAF1/CIP1) in Estrogen Receptor-negative breast cancer cells
22. Steroid hormone receptors in breast cancer management
23. The biology of breast cancer
24. Immunohistochemical markers of tumor prognosis in breast cancer in Egypt
25. Immunohistochemical co-expression of c-erbb-2/Neu oncoprotein, altered tumour suppressor (p53) protein, EGF-R and EMA in histological subtypes of infiltrating duct carcinoma of the breast
26. The role of the HER-2/neu oncogene in gynecologic cancers
27. HER-2/neu as a predictive marker of response to breast cancer therapy
28. Biologic and clinical significance of HER-2/neu (c-erbB-2) in breast cancer
29. The HER-2/neu oncogen in breast cancer: Prognostic factor, predictive factor and target for therapy
30. Overview of the biologic markers of breast cancer
31. p53 and survival in early onset breast cancer: Analysis of gene mutations, loss of heterozygosity and protein accumulation
32. Apoptosis and angiogenesis: Two promising tumor markers in breast cancer
33. Intratumor microvessel density as a prognostic factor in cancer
34. Microvessel density counting in breast cancer Slides vs. digital images
35. Surrogate markers of tumoral angiogenesis
36. Prognostic value of vascular endothelial growth factor in breast cancer
37. Immunohistochemical measurement of tumor vascular endothelial growth factor in breast cancer. A more reliable predictor of tumor stage than microvessel density or serum vascular endothelial growth factor
38. A unique form of proliferating cell nuclear antigen is present in malignant breast cells
39. Human breast cancer cells contain an error - Prone DNA replication apparatus
40. Vascular endothelial growth factor (VEGF) in breast cancer: Comparison of plasma, serum an tissue VEGF and microvessel density and effects of tamoxifen
41. Apoptosis in breast carcinoma
42. Bcl-2 protein expression and long-term survival in breast cancer
43. Prognostic evaluation of oestrogen-regulated protein immunoreactivity in ductal invasive (NOS) breast cancer
44. Prognostic significance of the estrogen-regulated proteins, cathepsin-D and pS2 in breast cancer
45. Sensitivity of serum tumor markers CEA and CA 15-3 in brest cancer recurrences and correlation with defferent prognostic factors
46. Breast cancer associated mucin: A review
47. Cancer-associated MUC1 mucin inhibitts human T-cell proliferation, which is reversible by IL-2
48. Analytical requirements and standarization of CA 15-3
49. Roles of BCRA1 and its interacting proteins
50. Abnormal expression of BCRA1 and BCRA2- interactive DNA- repair proteins in breast carcinomas
51. Immunolocalization of BCRA1 protein in normal breast tissue and sporadic invasive ductal carcinomas: A correlation with other biological parameters
52. BRCA1 mutations and breast cancer in the general population
53. p27 expression, a cyclin dependent kinase inhibitor in breast carcinoma
54. Prognostic significance of TGFa expression in breast cancer
55. Proteases as prognostic markers in cancer
56. The Rb family of cell cycle regulatory factors: Clinical implications
57. E2F-1: A proliferative marker of breast neoplasia
58. Stress response protein (srp-27) determination in primary human breast carcinomas: Clinical, histologic and prognostic correlations
59. Co-expression of the MDR1 Gene and Hsp27 in human ovarian cancer
60. Biological and clinical implications of heat shock protein 27000 (Hsp27): A review
61. Modification of growth in small heat shock (hsp 27) gene transfected breast carcinoma
62. Biología de las proteínas del shock térmico
63. Can breast cancer Hsp27 (Heat Shock Protein 27000) expression influence axillary lymph node status?
64. LEA, 135 expression: Its comparison with other prognostic biomarkers for patients with primary breast carcinoma
65. A sialoglycoprotein (LEA. 135) associated with favourable prognosis of patients with lymph node-negative primary breast carcinoma
66. Expression of topoisomerase II alpha is associated with rapid cell proliferation, aneuploidy, and c-erbB2 overexpression in breast cancer
67. Topoisomerase II alpha expression in breast cancer: Correlation with outcome variables
68. Human DNA topoisomerase II- Alpha: A new marker of cell proliferation in invasive breast cancer
69. Expression of glycodelin in human breast and breast cancer
70. Relationship between vascularization and proliferation in invasive breast cancer